NanoSyrinx

Coventry, United Kingdom

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.

$13.1M raised

Sep 2024

Series A

Top Investors

Octopus VenturesEli LillyBusiness Growth FundIQ CapitalFuture Planet Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NanoSyrinx raised?

NanoSyrinx has raised $13.1M in total funding. The most recent round was Series A. The last funding was announced in September 2024.

Who are NanoSyrinx's investors?

NanoSyrinx's investors include Octopus Ventures, Eli Lilly, Business Growth Fund, IQ Capital, Future Planet Capital.

Where is NanoSyrinx headquartered?

NanoSyrinx is headquartered in Coventry, United Kingdom.

What does NanoSyrinx do?

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.

What stage is NanoSyrinx at?

NanoSyrinx is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 10, 2024.

MLA

"NanoSyrinx — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/nanosyrinx. Accessed June 4, 2026.

APA

VCBacked. (2024). NanoSyrinx — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nanosyrinx

Wikipedia (cite web)

{{cite web |title=NanoSyrinx — Funding & Investors |url=https://www.vcbacked.co/company/nanosyrinx |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 10, 2024.